PL379703A1 - Środek farmaceutyczny jako stała postać dawkowana i sposób jego wytwarzania - Google Patents

Środek farmaceutyczny jako stała postać dawkowana i sposób jego wytwarzania

Info

Publication number
PL379703A1
PL379703A1 PL379703A PL37970304A PL379703A1 PL 379703 A1 PL379703 A1 PL 379703A1 PL 379703 A PL379703 A PL 379703A PL 37970304 A PL37970304 A PL 37970304A PL 379703 A1 PL379703 A1 PL 379703A1
Authority
PL
Poland
Prior art keywords
desmopressin
solid dosage
dosage form
manufacturing
diluent
Prior art date
Application number
PL379703A
Other languages
English (en)
Other versions
PL211799B1 (pl
Inventor
Hakan Lomryd
Helena Nicklasson
Lars-Erik Olsson
Original Assignee
Ferring B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32981781&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL379703(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring B.V. filed Critical Ferring B.V.
Publication of PL379703A1 publication Critical patent/PL379703A1/pl
Publication of PL211799B1 publication Critical patent/PL211799B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
PL379703A 2003-04-30 2004-04-30 Środek farmaceutyczny jako stała postać dawkowana i sposób jego wytwarzania PL211799B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03009659A EP1473029B1 (en) 2003-04-30 2003-04-30 Solid dosage form comprising desmopressin

Publications (2)

Publication Number Publication Date
PL379703A1 true PL379703A1 (pl) 2006-11-13
PL211799B1 PL211799B1 (pl) 2012-06-29

Family

ID=32981781

Family Applications (1)

Application Number Title Priority Date Filing Date
PL379703A PL211799B1 (pl) 2003-04-30 2004-04-30 Środek farmaceutyczny jako stała postać dawkowana i sposób jego wytwarzania

Country Status (18)

Country Link
EP (2) EP1473029B1 (pl)
JP (1) JP4597124B2 (pl)
KR (1) KR100766455B1 (pl)
CN (1) CN100438857C (pl)
AT (1) ATE291419T1 (pl)
AU (1) AU2004233596B2 (pl)
CA (1) CA2486833C (pl)
DE (1) DE60300414T2 (pl)
DK (1) DK1473029T3 (pl)
ES (1) ES2236640T3 (pl)
MX (1) MXPA05011591A (pl)
NO (1) NO331205B1 (pl)
NZ (1) NZ542653A (pl)
PL (1) PL211799B1 (pl)
PT (1) PT1473029E (pl)
RU (1) RU2290945C2 (pl)
SI (1) SI1473029T1 (pl)
WO (1) WO2004096181A2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
ATE301990T1 (de) * 2003-07-25 2005-09-15 Ferring Bv Pharmazeutische desmopressin-zubereitung als feste darreichungsform und methode zu ihrer herstellung
CA2490601C (en) * 2003-12-29 2006-05-02 Ferring B.V. Method for preparing solid dosage form of desmopressin
ES2319054B1 (es) 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
CN102423485B (zh) * 2011-12-08 2014-08-06 赵联华 含有醋酸去氨加压素的口服组合物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8306367L (sv) * 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
ATE253899T1 (de) * 1994-01-31 2003-11-15 Yamanouchi Pharma Co Ltd Intraoral löslicher formpressling und verfahren zu seiner herstellung
SE9400918L (sv) * 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US5849322A (en) * 1995-10-23 1998-12-15 Theratech, Inc. Compositions and methods for buccal delivery of pharmaceutical agents
US6210699B1 (en) * 1999-04-01 2001-04-03 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
JP2001139461A (ja) * 1999-11-10 2001-05-22 Ohta Pharmaceut Co Ltd 速崩壊性錠剤
JP4596586B2 (ja) * 2000-01-27 2010-12-08 旭化成ケミカルズ株式会社 トレハロース粒子
JP4019374B2 (ja) * 2001-07-27 2007-12-12 アステラス製薬株式会社 口腔内速崩壊錠用徐放性微粒子含有組成物およびその製造法

Also Published As

Publication number Publication date
AU2004233596B2 (en) 2010-04-08
AU2004233596A1 (en) 2004-11-11
KR100766455B1 (ko) 2007-10-15
PT1473029E (pt) 2005-05-31
CN1780608A (zh) 2006-05-31
JP2006524663A (ja) 2006-11-02
EP1473029B1 (en) 2005-03-23
CA2486833C (en) 2005-08-02
PL211799B1 (pl) 2012-06-29
DE60300414D1 (de) 2005-04-28
NZ542653A (en) 2008-04-30
EP1473029A1 (en) 2004-11-03
NO331205B1 (no) 2011-10-31
ATE291419T1 (de) 2005-04-15
RU2290945C2 (ru) 2007-01-10
SI1473029T1 (en) 2005-10-31
KR20060012592A (ko) 2006-02-08
NO20055016L (no) 2005-10-27
DE60300414T2 (de) 2006-05-11
EP1670439A2 (en) 2006-06-21
CN100438857C (zh) 2008-12-03
WO2004096181A2 (en) 2004-11-11
RU2005131494A (ru) 2006-03-20
MXPA05011591A (es) 2005-12-15
CA2486833A1 (en) 2004-11-11
ES2236640T3 (es) 2005-07-16
DK1473029T3 (da) 2005-04-18
WO2004096181A3 (en) 2004-12-23
JP4597124B2 (ja) 2010-12-15

Similar Documents

Publication Publication Date Title
CA2339991A1 (en) Microemulsions as solid dosage forms for oral administration
WO2002101412A3 (en) Spray freeze-dried compositions
IL187591A0 (en) Pharmaceutical composition as solid dosage from and method for manufacturing thereof
AU2003273413A1 (en) Pharmaceutically active oligosaccharide conjugates
AU2001236207A1 (en) Powder formulation
ZA992951B (en) N-substituted aminotetralins as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders.
WO2004108162A3 (en) Controlled release pharmaceutical composition
WO2010063476A3 (en) Solid dosage forms of bendamustine
WO2004078105A3 (fr) Composition de fondaparinux sodique de haute purete
DE602004011966D1 (en) Heterocyclylverbindungen
GB0109122D0 (en) Novel compounds
ATE329581T1 (de) Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydr -2h-(1, 3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet
TW200605897A (en) Powder comprising new compositions of oligosaccharides and methods for their preparation
MY134340A (en) Pharmaceutical formulation having a masked taste and method for the production thereof
MA26346A1 (fr) Compositions de preparation contenant des composes actifs au plan physiologique et instables aux acides et leur procede de production.
PL379703A1 (pl) Środek farmaceutyczny jako stała postać dawkowana i sposób jego wytwarzania
UA89349C2 (uk) Таблетка без покриття, яка містить оланзапін, та спосіб її одержання
CA2344686A1 (en) High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
IL200447A0 (en) Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
WO2002006299A3 (en) Therapeutic uses for aminosterol compounds
HUP0401912A3 (en) Pharmaceutically acceptable salts of 20(s)-camptothecins, process for their preparation and pharmaceutical compositions containing them
WO2005020876A3 (en) Pharmaceutical composition, method of manufacturing and therapeutic use thereof
JP2007297309A (ja) 経口固形製剤
GB2415377A (en) Hepatoprotective pharmaceutical composition comprising a mixture of coumarinolignoids and process for preparation thereof
WO2004000864A3 (en) 11-c-substituted ketolides

Legal Events

Date Code Title Description
RECP Rectifications of patent specification